Trader Note — 11095 total
CBZ enters the week with its most notable analyst action in months — a fresh downgrade from Barrington Research that dropped the stock to Market Perform just as short sellers are quietly exiting their positions. The…
IGPT, Invesco's AI and Next Gen Software ETF, presents an unusual split this week: short interest has collapsed to near nothing, yet the borrow market has tightened to its most constrained level of the past year. The…
Neste Oyj enters the final weeks before its October results with a sharp price recovery and a borrow market that remains remarkably relaxed — an unusual combination for a stock still nursing fresh earnings wounds. The…
Samsung Electronics enters the week with a striking disconnect: the stock has fallen nearly 8% in seven days to ₩248,500, yet the analyst consensus implies almost 90% upside to a mean target of ₩475,850 — one of the…
Gold Fields Limited heads into the back half of September with a sharp weekly loss that the short-selling community is notably not chasing. The stock dropped 9.6% across the week to close at ZAR 696.43 on Tuesday — a…
SAN heads into its October earnings window with bears effectively absent from the trade — the interesting tension this week is less about short pressure and more about why the stock keeps sliding despite an almost…
BRKM5 is up nearly 8% on the week and has added 8% over the past month — a sharp recovery for a stock that spent much of 2026 under heavy pressure — yet the lending market and short positioning data that once made this…
VALE3 enters the week of September 15 down nearly 6% over the past five sessions, underperforming most of its peer group even as iron ore pricing remains the dominant headwind and two major institutional holders move…
ENI has had a strong week on the Milan bourse, gaining nearly 4% to close at €24.43 — but the more interesting development sits in the lending market, where borrowing costs have doubled in a month even as the actual…
Novartis heads into the final stretch of Q3 with a 7% monthly pullback, a clean borrow market, and Q4 earnings on the horizon — the tension is whether the stock's defensive credentials can hold while momentum…
BYD Company (1211) enters the week in a peculiar position: short sellers have been quietly covering even as the stock falls, creating a divergence worth watching ahead of the next earnings event in late October. The…
SK hynix Inc. enters the final stretch of September having dropped 5.7% on the week to ₩1,690,000 — a reversal that stands out less because of anything specific to the company and more because the broader memory and…
Eisai Co., Ltd. enters the mid-September session with a quiet but persistent build in short-side conviction — even as the stock posts its best weekly gain in a month. The most notable development this week is the ORTEX…
GMAB is quietly outperforming a weak biotech tape this week, even as the teclistamab enrollment cloud from earlier in September continues to hang over the thesis. The most telling data point right now is not where…
Taiwan Semiconductor Manufacturing Company heads into its October 16 earnings window having shed 3.4% on the week to TWD 2,385 — a controlled retreat that follows a brief intraday peak near TWD 2,470, and that leaves…
Honda Motor closed at ¥1,675 on Tuesday, up 4% on the week — a solid gain that largely keeps pace with the Japanese auto sector's broad September recovery. The more interesting story, though, is a quieter structural…
Toyota Motor enters the final stretch before its October 30 earnings with an unusual tension: the stock is drifting near flat on the month while the cost to borrow shares has tripled over the same period — a divergence…
BP has turned a corner on the charts — up 11% in a month, 5.5% on the week — yet the lending market signals almost no bearish conviction, leaving the stock's next move to be determined by fundamentals and institutional…
Nokia heads into its October earnings window with a stock down 5.4% on the week and a borrow market that has quietly changed shape — cost to borrow has tripled since late August, even as the lending pool remains…
AstraZeneca heads into the final weeks before its October 30 earnings with one clear signal from within: the Non-Executive Chairman just bought stock in the open market, even as borrowing costs have crept to a six-week…
